i agrrr as well hope they are not just kicking the can i have been seen here since 2022 seen my paper value drop but hearing the MD attending multiple conferences and roadshows with lot of interest being shown by licensing pharma partners as he says so. now the narrative is phase 1 extension study is what will determine this company future to survive in this tough asx micro cap market. i feel its the last roll of the dice. i am quite confident that results should be favorable but if that doesnt close out of a deal or get co funding it will prove CEO is full of shit and only led investors on what i have been very disappointed is management has not bought shares on market if your on brink of imminent deal which he keeps bragging about in his webinars about being multiples of current MC then why arent you dipping in your pockets.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)